Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • IQV vs GSK✓SelectedUSD · GSKIQV vs GSK performance historyLatest closeAs of-2.83%11/19
Stock and ETF performance explorer

IQV vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+495.0%
GSK return
+82.2%
Excess return
+412.8%
Maximum drawdown
-51.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.8%-1.6%-1.3%-2.1%
7D-7.6%-4.7%-2.9%-5.5%
30D-6.5%-4.7%-1.8%-4.6%
3M+0.5%-8.8%+9.3%+4.4%
6M+44.7%-4.6%+49.3%+46.9%
YTD+11.2%+1.0%+10.2%+8.3%
1Y+15.2%+6.9%+8.3%+9.1%
3Y+22.3%+52.5%-30.2%-5.5%
5Y-6.6%+40.3%-46.9%-26.4%
10Y+213.7%+99.0%+114.7%+105.9%
All+495.0%+82.2%+412.8%+293.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling